This federal contract award is for the pharmaceutical product VYNDAQEL 20 MG CAPSULE UD 120S, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $12,960.30 firm fixed-price delivery order contract has an ultimate completion date of August 2, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S. The contract has an ultimate completion date of May 20, 2024 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 120 capsules of the medication VYNDAQEL 20 MG. The award, valued at $12,960.30, is a firm fixed-price delivery order contract with a completion date of June 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 firm fixed-price delivery order contract is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a specialty medication. The contract has a June 20, 2024 ultimate completion date and was awarded on May 29, 2024. This contract award is not designated under any set-aside program. AmerisourceBergen holds a...
This federal contract award, with ID SPE2DB22D1017|SPE2DB24FF8RH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 firm fixed-price delivery order is for the medical product VYNDAQEL 20 MG CAPSULE UD 120S. The contract has an ultimate completion date of June 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 firm-fixed-price delivery order is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a specialty medication. The contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 delivery order contract is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a specialty medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award, valued at $18,157.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has a completion date of November 18, 2024 and was awarded on October 25, 2024. The award is not designated as a set-aside contract. In addition to this...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has a ceiling value of $13,408.24 and a period of performance through April 10, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $12,960.30 firm fixed-price contract is for the supply of 120-count capsules of the pharmaceutical product VYNDAQEL 20 MG. This delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military...